Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

[Prognostic role of NT-proBNP in emergency department in the elderly with acute heart failure].

Martín Sánchez FJ, Covarrubias M, Terán C, Llorens P, Herrero P, Jacob J, Gil V, Fernández C, Miró O; grupo ICA-SEMES.

Rev Esp Geriatr Gerontol. 2013 Jul-Aug;48(4):155-60. doi: 10.1016/j.regg.2012.11.010. Epub 2013 Mar 23. Spanish.

PMID:
23528263
2.

Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.

Noveanu M, Breidthardt T, Potocki M, Reichlin T, Twerenbold R, Uthoff H, Socrates T, Arenja N, Reiter M, Meissner J, Heinisch C, Stalder S, Mueller C.

Crit Care. 2011;15(1):R1. doi: 10.1186/cc9398. Epub 2011 Jan 5.

3.

The ability of NT-proBNP to detect chronic heart failure and predict all-cause mortality is higher in elderly Chinese coronary artery disease patients with chronic kidney disease.

Fu S, Luo L, Ye P, Yi S, Liu Y, Zhu B, Wang L, Xiao T, Bai Y.

Clin Interv Aging. 2013;8:409-17. doi: 10.2147/CIA.S42700. Epub 2013 Apr 15.

4.

NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality.

Bayés-Genís A, Lopez L, Zapico E, Cotes C, Santaló M, Ordonez-Llanos J, Cinca J.

J Card Fail. 2005 Jun;11(5 Suppl):S3-8.

PMID:
15948093
5.

Connective tissue growth factor (CTGF/CCN2): diagnostic and prognostic value in acute heart failure.

Behnes M, Brueckmann M, Lang S, Weiß C, Ahmad-Nejad P, Neumaier M, Borggrefe M, Hoffmann U.

Clin Res Cardiol. 2014 Feb;103(2):107-16. doi: 10.1007/s00392-013-0626-6. Epub 2013 Oct 22.

PMID:
24146089
6.

Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.

Kubler P, Jankowska EA, Majda J, Reczuch K, Banasiak W, Ponikowski P.

Int J Cardiol. 2008 Oct 13;129(3):373-8. Epub 2007 Dec 4.

PMID:
18054808
7.

[Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure].

Manzano-Fernández S, Januzzi JL, Boronat García M, Bonaque-González JC, Muñoz-Esparza C, Albaladejo-Otón MD, Pastor-Pérez FJ, Pastor P, Valdés M, Pascual-Figal DA.

Rev Esp Cardiol. 2011 May;64(5):365-72. doi: 10.1016/j.recesp.2010.10.017. Epub 2011 Mar 11. Spanish.

8.

Comparison of prognostic value of red cell distribution width and NT-proBNP for short-term clinical outcomes in acute heart failure patients.

He W, Jia J, Chen J, Qin S, Tao H, Kong Q, Xue Q, Zhang D.

Int Heart J. 2014;55(1):58-64. Epub 2014 Jan 27.

9.

Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.

Hoffmann U, Espeter F, Weiß C, Ahmad-Nejad P, Lang S, Brueckmann M, Akin I, Neumaier M, Borggrefe M, Behnes M.

BMC Cardiovasc Disord. 2015 Jun 14;15:50. doi: 10.1186/s12872-015-0026-0.

10.

A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.

Salah K, Kok WE, Eurlings LW, Bettencourt P, Pimenta JM, Metra M, Bayes-Genis A, Verdiani V, Bettari L, Lazzarini V, Damman P, Tijssen JG, Pinto YM.

Heart. 2014 Jan;100(2):115-25. doi: 10.1136/heartjnl-2013-303632. Epub 2013 Oct 31.

11.

The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age.

Frankenstein L, Clark AL, Goode K, Ingle L, Remppis A, Schellberg D, Grabs F, Nelles M, Cleland JG, Katus HA, Zugck C.

Heart. 2009 May;95(10):825-9. doi: 10.1136/hrt.2008.158626. Epub 2009 Jan 15.

PMID:
19147626
12.

Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.

Januzzi JL Jr, Sakhuja R, O'donoghue M, Baggish AL, Anwaruddin S, Chae CU, Cameron R, Krauser DG, Tung R, Camargo CA Jr, Lloyd-Jones DM.

Arch Intern Med. 2006 Feb 13;166(3):315-20.

PMID:
16476871
13.

Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.

Eckstein J, Potocki M, Murray K, Breidthardt T, Ziller R, Mosimann T, Klima T, Hoeller R, Moehring B, Sou SM, Rubini Gimenez M, Morgenthaler NG, Mueller C.

Heart. 2012 Oct;98(20):1518-22. Epub 2012 Aug 3.

PMID:
22865868
14.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

15.

Determination of a predictive cutoff value of NT-proBNP testing for long-term survival in ED patients with acute heart failure.

Velibey Y, Golcuk Y, Golcuk B, Oray D, Atilla OD, Colak A, Kurtulmus Y, Erbay AR, Yilmaz A, Eren M.

Am J Emerg Med. 2013 Dec;31(12):1634-7. doi: 10.1016/j.ajem.2013.08.033. Epub 2013 Sep 18.

PMID:
24055249
16.

Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.

Michtalik HJ, Yeh HC, Campbell CY, Haq N, Park H, Clarke W, Brotman DJ.

Am J Cardiol. 2011 Apr 15;107(8):1191-5. doi: 10.1016/j.amjcard.2010.12.018. Epub 2011 Feb 4.

PMID:
21296322
17.

Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure.

Park HS, Kim H, Sohn JH, Shin HW, Cho YK, Yoon HJ, Nam CW, Hur SH, Kim YN, Kim KB, Park HJ.

Korean J Intern Med. 2010 Sep;25(3):253-9. doi: 10.3904/kjim.2010.25.3.253. Epub 2010 Aug 31.

18.

N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.

Rutten JH, Steyerberg EW, Boomsma F, van Saase JL, Deckers JW, Hoogsteden HC, Lindemans J, van den Meiracker AH.

Am Heart J. 2008 Jul;156(1):71-7. doi: 10.1016/j.ahj.2008.02.021. Epub 2008 May 27.

PMID:
18585499
19.

Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.

Chuang CP, Jong YS, Wu CY, Lo HM.

Am J Cardiol. 2014 Mar 1;113(5):845-50. doi: 10.1016/j.amjcard.2013.11.039. Epub 2013 Dec 12.

PMID:
24406111
20.

Predictive cutoff point of admission N-terminal pro-B-type natriuretic peptide testing in the ED for prognosis of patients with acute heart failure.

Golcuk Y, Golcuk B, Velibey Y, Oray D, Atilla OD, Colak A, Kurtulmus Y, Yildirim A, Eren M.

Am J Emerg Med. 2013 Aug;31(8):1191-5. doi: 10.1016/j.ajem.2013.04.038. Epub 2013 Jun 4.

PMID:
23759684
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk